Article
The potential for aromatase inhibition in breast cancer prevention.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Dec 2001
Lønning P E, Kragh L E, Erikstein B, Hagen A, Risberg T, Schlichting E, Geisler J
Abstract excerpt
Although SERMs are currently being evaluated and are approved for breast cancer prevention in several countries, aromatase inhibitors and inactivators may represent interesting options in this setting. The encouraging results revealing these drugs to be superior to conventional therapy in metastatic breast cancer confirm their therapy efficacy and suggest that they may also have a role in adjuvant therapy and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.